CA-SCIENTIST.COM
11.7.2024 13:56:27 CEST | Business Wire | Press release
BioPharmCatalyst (BPC), a division of Scientist.com, today announced that members with an “Elite” and “Elite Plus” subscription now get full access to Trial Insights, which curates and enriches publicly available data from clinicaltrials.gov and other data sources. Trial Insights creates filterable, customizable dashboards on clinical trial status, sponsors and new medicines, enabling investors to make smarter, data-driven decisions.
“The ability to track drugs throughout their development cycle based on catalyst events not only drives biotech investor decision making, but also helps scientists keep up to date with clinical trials in their research areas,” stated John Gagliano, Senior Director, BioPharmCatalyst. “The addition of Trial Insights provides subscribers with real time insight into clinical trial results that were previously difficult and time consuming to gather through publicly available sources.”
BPC equips investors in the biotech and pharmaceutical industries with a comprehensive suite of tools for making informed investment decisions. These include an FDA calendar, a PDUFA calendar, an earnings calendar, the latest IPO information and a company’s cash database. With Trial Insights, Elite and Elite Plus subscribers can closely monitor ongoing clinical trials being conducted around the world in real time through their existing account.
To access BioPharmCatalyst’s investing tools and start a free trial, visit www.biopharmcatalyst.com. To learn more about Trial Insights, visit www.biopharmcatalyst.com/trial-insights.
About Scientist.com
Scientist.com is the world's leading AI-enabled marketplace for scientific research. The marketplace simplifies drug discovery research, saving time and money and providing access to the latest innovative tools and technologies. Scientist.com operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, over 100 biotechnology companies and the US National Institutes of Health (NIH).
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240711495417/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Global styrker sine globale mobilitetskompetencer med tilføjelsen af Courdid BV10.6.2026 22:05:00 CEST | Pressemeddelelse
Andersen Global har indgået en samarbejdsaftale med Courdid BV, som er et hollandsk konsulentfirma inden for global mobilitet, hvilket yderligere styrker organisationens rådgivningskapacitet for internationale arbejdsstyrker og expats. Courdid BV blev grundlagt for næsten to årtier siden og tilbyder en bred vifte af rådgivningstjenester inden for lønsums- og lønskat, expatbeskatning, lønudbetaling, immigration samt employer of record-løsninger. Virksomheden samarbejder med multinationale arbejdsgivere, offentlige institutioner og professionelle serviceudbydere om at levere praktisk og skræddersyet rådgivning om komplekse internationale arbejdsstyrkeforhold – kendetegnet ved en kundeorienteret tilgang, der prioriterer tilgængelighed og personlig service. "Vi bestræber os på at være praktiske og relevante for vores klienter, særligt inden for områder, der ofte er unødigt komplekse," siger Jean-Paul van ’t Hof, der er administrerende partner i Courdid BV. "Ved at blive en samarbejdende vi
TestMu AI Announces Day-Zero Support for macOS Golden Gate and iOS 27 Beta Following WWDC 202610.6.2026 21:52:00 CEST | Press release
Developers can now test websites, web applications, and mobile apps on Apple's latest operating systems before their public release TestMu AI (formerly LambdaTest), the world's first full-stack Agentic AI Quality Engineering platform, today announced day-zero support for Apple's newly unveiled operating systems, macOS Golden Gate and iOS 27 Beta, across its cloud testing platform. Announced at Apple's Worldwide Developers Conference (WWDC) 2026, macOS Golden Gate and iOS 27 introduce significant platform updates that will impact application compatibility, user experience, and performance. Both operating systems are now available for testing on TestMu AI, the same day Apple released its beta versions, allowing engineering teams to identify issues months before the stable rollout reaches millions of users worldwide. macOS Golden Gate is available through the TestMu AI Real Time Testing platform, while iOS 27 Beta is available on TestMu AI Real Device Cloud across the latest iPhones and i
Pure Lithium Corporation Named World Economic Forum Technology Pioneer10.6.2026 20:10:00 CEST | Press release
Lithium metal battery innovator joins a select global cohort of 100 pioneering companies shaping the future of energy and advanced materials Pure Lithium Corporation, a disruptive lithium metal battery technology company, is pleased to announce that the company has been selected as a 2026 Technology Pioneer by the World Economic Forum. Launched in 2000, the Technology Pioneers is a leading community for companies from around the world that are shaping the future through breakthrough technologies and innovations. These companies are selected for their potential to have a significant impact on business and society and are invited to engage with public and private sector leaders through the World Economic Forum’s global platform. “We are delighted to be selected as a World Economic Forum Technology Pioneer. I would like to express my gratitude to the World Economic Forum for this honor,” said Pure Lithium Founder, Chairman and CEO, Emilie Bodoin. “Pure Lithium’s selection is a testament t
Visa Partners with OpenAI to Power the Next Generation of AI Commerce10.6.2026 20:00:00 CEST | Press release
New collaboration brings Visa’s global payment networkto one of the largest AI platforms and aims to support seamless, secure transactions and broader AI-powered use cases across commerce environments supported by agents Visa (NYSE: V) today announced a strategic collaboration with OpenAI to enable secure Visa payments within agentic commerce, enabling seamless and trusted payments across OpenAI. The companies made the announcement at the Visa Payments Forum in San Francisco. Through the partnership, Visa will provide its global network, credentialing capabilities and security infrastructure to support agentic commerce experiences, helping consumers and businesses interact and transact with confidence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260610422687/en/ The collaboration is part of the broader Visa Intelligent Commerce initiative, which is focused on extending secure payment capabilities into new digital environm
Visa Announces New AI, Stablecoin and Token Innovations to Power Intelligent, Programmable Commerce at Visa Payments Forum10.6.2026 20:00:00 CEST | Press release
New Agent Scoring, Agentic Registry and Large Transaction Model capabilities, stablecoin settlement and token enhancements support the next gen of digital commerce At Visa Payments Forum 2026, Visa (NYSE: V) today announced new AI, stablecoin and token capabilities designed to help clients unlock the next generation of commerce. These innovations reflect a simple objective: ensuring trust, security and control evolve alongside increasingly fast, automated and intelligent commerce experiences. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260610464331/en/ In a keynote presentation, Jack Forestell, Chief Product & Strategy Officer at Visa, outlined how two foundational shifts—artificial intelligence and stablecoins—are transforming both the front end and back end of money movement, and how Visa is enabling clients to participate. “AI is transforming the front end of commerce. Stablecoins are reshaping the back end,” said Fore
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom